Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemo-naïve patients with unresectable malignant pleural mesothelioma

BACKGROUND: We conducted a phase I trial of cisplatin-pemetrexed-imatinib mesylate, an oral PDGFR inhibitor, in chemo-naive MPM patients. METHODS: A standard 3+3 dose-escalating trial was used with the endpoints of MTD, response rate, survival, safety/toxicity and tumor PDGFR levels. RESULTS: 17 MPM...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Lung Cancer
Autors principals: Tsao, AS, Harun, N, Lee, J.J, Heymach, J, Pisters, K, Hong, WK, Fujimoto, J, Wistuba, I
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5080907/
https://ncbi.nlm.nih.gov/pubmed/24492162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2013.12.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars